Delivery Order SPE2DR25D2104-SPE2DR26F3TYD
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,205.75 firm fixed-price delivery order by the Defense Logistics Agency on June 2, 2025, for Nucynta ER 200 mg tablets (60-count supply). The contract, which carries an ultimate completion date of June 3, 2025, represents a non-competitive award and serves the federal medical supply chain supporting military and veteran healthcare systems. This delivery order is issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on November 25, 2025, for the supply of Nucynta ER Tablets 100mg with a ceiling value of $12,560.28. The competitively awarded, firm fixed-price delivery order is funded by the Defense Department's Medical Supply Chain and is due for completion by November 26, 2025. This award represents a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Nucynta ER 100 mg tablets (60-count packaging) with a ceiling value of $2,105.08. This firm fixed-price, competitively awarded delivery order is scheduled for completion by January 20, 2026, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Nucynta ER 150 mg tablets (60-count packages) with a contract ceiling value of $1,352.72. This competitively awarded, firm fixed-price delivery order is scheduled for completion by January 6, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Nucynta ER 150 mg tablets (60-count units) with a ceiling value of $6,598.58 and an ultimate completion date of December 1, 2025. This is a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Nucynta ER 50 mg tablets in quantities of 60 units. The contract carries a ceiling value of $1,414.00 and features firm fixed pricing with an ultimate completion date of July 25, 2025. This is a non-set-aside award issued competitively and represents a child contract under AmerisourceBergen's existing...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for NUCYNTA ER 100 MG tablets (60-count) by the Defense Logistics Agency on January 12, 2026. The contract is structured as a firm fixed-price delivery order with a ceiling value of $2,609.58 and an ultimate completion date of January 13, 2026. This award is non-set-aside and competitively awarded, reflecting AmerisourceBergen's capability to meet federal...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 26, 2025, for the supply of Nucynta ER 50 mg tablets (60-count units) with a contract value of $1,990.55. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The contract is set for ultimate completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 3, 2025, for the supply of Nucynta ER 150 mg tablets (60-count). The contract is competitively awarded with no set-aside designation and carries a ceiling value of $2,817.62 under a firm fixed-price arrangement. This delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,156.26 by the Defense Logistics Agency (DLA) on December 11, 2025, for the supply of Nucynta ER 50 mg tablets (60-count packages). The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania, with delivery required by December 12,...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3TYDDelivery Order
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order by the Defense Logistics Agency on January 20, 2026, for the supply of Nucynta ER 150 mg tablets (60-count units) valued at $2,841.84. This is a firm fixed-price, non-set-aside competitive award with a completion date of January 21, 2026. The contractor will perform from its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion vehicle that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive contract portfolio demonstrates capability across diverse therapeutic domains including pain management, neurology, diabetes, and infectious disease treatments. This award reflects the ongoing need for controlled pharmaceutical products within the military healthcare supply chain, with DLA Troop Support Medical planning to expand pharmaceutical prime vendor programs regionally to include multiple contractors in coming years.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 1/19/26 |